EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Uranium Royalty Corp.
UROY

UROY Uranium Royalty Corp.

Uranium Royalty Corp. · NASDAQ
Market Closed
4.36
▼ ⁦-3.22%⁩ (-0.14)
Market Cap$638.4M
Beta1.39
52w Low52w High
2.565.52
Last Week
⁦+1.52%⁩
Last Month
⁦+5.45%⁩
Last 3 Months
⁦+22.33%⁩
Last Year
⁦+47.13%⁩
EL7 Factor Analysis
How we score this
Overall99
Excellent — top fifth of the marketSuper StockF 6/8Better than 99% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
79
15.7x▲17.8xTop tier
▸
Growth
100
—7.1%Top tier
▸
Quality
73
13.9%▲4.5%Top tier
▸
Safety
91
—2.6xTop tier
▸
Capital Return
65
—2.12%Around median
▸
Momentum
69
45.6%▲2.9%Top tier
▸
Sentiment
77
1▼3Top tier
Fair Value
Low confidenceCurrent price$4.36
Analyst target · 1 analysts
$3.75
⁦-14%⁩
See it slightly overvalued
Range ⁦$3.75–$3.75⁩
vs
DCF (estimate)
$14
⁦+221%⁩
Sees it clearly undervalued
⁦10.5⁩% discount · ⁦4⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$3.75–$14⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$3.75
⁦-13.9%⁩
Current Price $4.36·Median $3.75
Low
$3.75
High
$3.75
Street summary

Uranium Royalty Corp (UROY) Price Target Analysis

UROY stock is seeing complete stability in its price target at $3.75, representing a 5.3% premium over the current price of $3.56. There has been no change to this target over the past thirty days, with zero Analyst Dispersion noted as there is only one analyst covering the stock in the current data, making the future outlook dependent on a single-sided estimate.

As of 2026-08-05
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 4.40
Buy
Analyst coverage
5
Buy conviction
100%
High
Target dispersion
0%
Analyst ratings over time5 analysts rating
2
3
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.83 → 4.40
Recent analyst moves
  • = Reiterate2026-07-29
    National Bank
    Outperform
  • ⬆ Upgrade2026-04-21
    Raymond James
    Market PerformOutperform
  • = Reiterate2026-01-14
    Raymond James
    Market Perform
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    15.68x
    3.56x28.47x
    Cheap
  • Forward P/E
    —
    —
  • EV / EBITDA
    7.74x
    2.12x16.98x
    Cheap
  • FCF Yield
    20.4%
    -21.0%15.7%
    Exceptional
  • Revenue Growth YoY
    1553.7%
    -19.7%63.1%
    Exceptional
  • EPS Growth YoY
    1075.0%
    -141.8%256.7%
    Exceptional
  • Gross Margin
    30.6%
    7.8%72.1%
    Near median
  • ROIC
    13.9%
    -12.7%20.6%
    Strong
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated

Company Overview

Uranium Royalty Corp. (UROY) reported fiscal year 2026 revenue of $257.9 million, gross profit of $78.8 million, and net income of $55.5 million, with earnings per share of $0.39. This resulted in a gross profit margin of approximately 30.6% and a net income margin of approximately 21.5%. The data does not include a breakdown of revenue sources, products, or segments, so the operating analysis is limited to the reported financial results.

The fourth quarter of fiscal year 2026 made the largest contribution to the results, with revenue of $208.0 million, gross profit of $69.3 million, net income of $50.0 million, and earnings per share of $0.3494. This equates to a gross margin of approximately 33.3% and a net income margin of approximately 24.0%. The quarter also represented approximately 80.7% of fiscal year 2026 revenue and approximately 90.1% of its net income.

The quarterly comparison shows sharp variation in the scale of activity: the third quarter of fiscal year 2026 recorded revenue of $16.7 million and net income of $2 million, while the second quarter of fiscal year 2026 recorded revenue of approximately $41.4 thousand and net income of $2.1 million. The figures for the twelve months ended in fiscal year 2026 matched the annual figures, at revenue of $257.9 million and net income of $55.5 million.

What's Driving the Stock

  • The significant increase in the fourth quarter of fiscal year 2026 represents the clearest financial driver for the stock, as revenue reached $208.0 million compared with $16.7 million in the third quarter of fiscal year 2026.
  • Profitability improved in the fourth quarter of fiscal year 2026, with the gross profit margin reaching approximately 33.3% compared with approximately 25.1% in the third quarter of fiscal year 2026, while net income increased from $2 million to $50.0 million.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • Uranium Royalty Corp. achieved annual earnings per share of $0.39 in fiscal year 2026, of which $0.3494 came from the fourth quarter alone, illustrating the extent to which the annual result depended on that quarter's performance.
  • Insider activity during the three months ended with the latest transaction on July 30, 2026 recorded two purchases and no sales, with positive net activity of approximately 30.8 thousand, while the overall signal was classified as neutral.
  • Analysts have a consensus rating of "Buy" and an average price target of $3.75, but the highest and lowest targets are identical at the same level, making the available estimate range extremely limited.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The company achieved net income of $55.5 million and earnings per share of $0.39 in fiscal year 2026, after the fourth quarter of fiscal year 2026 alone generated net income of $50.0 million.
    • +The gross profit margin rose to approximately 33.3% in the fourth quarter of fiscal year 2026, exceeding the fiscal year 2026 margin of approximately 30.6% and the previous quarter's margin of approximately 25.1%.
    • +The analyst consensus rating of "Buy" supports the positive outlook, while the available target of $3.75 is approximately 46.5% above the 52-week range low of $2.56.
    • +Insider activity adds limited support; two purchases and zero sales were recorded during the three months through July 30, 2026, although the signal remained classified as neutral rather than positive.

    ▼ Selling Case6 pts

    • −The concentration of approximately 80.7% of fiscal year 2026 revenue and approximately 90.1% of its net income in the fourth quarter of fiscal year 2026 reveals high quarterly variability, making the sustainability of the annual results dependent on a repeat of an exceptionally large quarter.
    • −Revenue jumped from $16.7 million in the third quarter of fiscal year 2026 to $208.0 million in the fourth quarter, while it was only $41.4 thousand in the second quarter; this substantial volatility limits the ability to extrapolate a stable growth trajectory from the quarters presented.
    • −No price-to-earnings ratio is available in the data despite earnings per share of $0.39 in fiscal year 2026, preventing a price assessment based on a fixed earnings multiple and increasing uncertainty about how much of the fourth quarter's earnings is reflected in the valuation.
    • −The analyst target is $3.75, approximately 32.1% below the 52-week range high of $5.52, reflecting a substantial gap between the annual trading peak and the available analyst valuation level.
    • −The highest and lowest targets are identical at $3.75, so the consensus does not provide an independent range of scenarios that can be used to measure variation in analyst expectations.
    • −Despite two insider purchases and no sales during the three months through July 30, 2026, the signal was classified as neutral and net activity amounted to only approximately 30.8 thousand, so its investment significance remains limited.

    Valuation

    The analyst consensus is "Buy," with an average price target of $3.75, while the highest and lowest targets are identical at the same figure; this reduces the apparent breadth of the sample or variation in valuation scenarios within the data. The target is approximately 46.5% above the 52-week range low of $2.56, but approximately 32.1% below its high of $5.52. No price-to-earnings ratio is available despite earnings per share of $0.39 in fiscal year 2026, so the valuation should be viewed in light of the substantial dependence of earnings on the fourth quarter of fiscal year 2026.

    BuyAnalyst target: $3.75(-13.9%)

    Figures in the text are as of 2026-09-09; the live price is shown at the top of the page.

    FAQ

    What were UROY's key results in fiscal year 2026?

    Uranium Royalty Corp.'s revenue in fiscal year 2026 was approximately $257.9 million, and gross profit was $78.8 million. The company recorded net income of $55.5 million and earnings per share of $0.39. These results equate to a gross profit margin of approximately 30.6% and a net income margin of approximately 21.5%.

    Why was the fourth quarter of fiscal year 2026 important to UROY's results?

    The fourth quarter of fiscal year 2026 generated revenue of $208.0 million and gross profit of $69.3 million. Net income was $50.0 million and earnings per share were $0.3494 during the quarter. The quarter represented approximately 80.7% of fiscal year 2026 revenue and approximately 90.1% of its net income, making it the decisive factor in the annual result.

    Do UROY's results show stable quarterly growth?

    The figures presented are insufficient to establish a stable quarterly growth trajectory because they show wide variation between quarters. Revenue was approximately $41.4 thousand in the second quarter of fiscal year 2026, then $16.7 million in the third quarter, before reaching $208.0 million in the fourth quarter. Net income also increased from $2 million in the third quarter to $50.0 million in the fourth quarter of fiscal year 2026.

    What is the analyst assessment of UROY stock?

    The available analyst consensus is "Buy," with an average price target of $3.75. The highest and lowest targets are identical at $3.75, so the data does not show a range of multiple estimates. This target lies between the 52-week range low of $2.56 and its high of $5.52, and is approximately 32.1% below the high.

    What does insider activity reveal about UROY?

    During the three months ended with the latest transaction on July 30, 2026, the data recorded two insider purchases and no sales. Net activity was approximately 30.8 thousand, but the overall signal was classified as neutral. Therefore, the activity provides only limited support and does not by itself change the assessment of the financial results or the risks of quarterly volatility.

    What are the main valuation risks for UROY?

    The data does not provide a price-to-earnings ratio for the stock, although earnings per share were $0.39 in fiscal year 2026. In addition, $0.3494 of earnings per share came from the fourth quarter of fiscal year 2026 alone, meaning that most of the annual profitability was concentrated in a single quarter. The identical highest and lowest analyst targets of $3.75 further limit the information available for testing different valuation scenarios.